SCHEMBL5732265

SCHEMBL5732265

Nc1ncnc2c1nc(O)n2C1CCCC1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 7/20 0.69
▸ ADORA3 P0DMS8 5/20 0.69
▸ ADORA1 P30542 5/20 0.69
▸ ADORA2B P29275 3/20 0.69
▸ PI4KB Q9UBF8 5/20 0.54
▸ PI4KA P42356 4/20 0.54
▸ PI4K2B Q8TCG2 4/20 0.54
▸ PI4K2A Q9BTU6 4/20 0.54
▸ FBP1 P09467 2/20 0.53
▸ CYP1A2 P05177 1/20 0.48
▸ CYP3A4 P08684 1/20 0.48
▸ NFKB1 P19838 1/20 0.48
▸ THPO P40225 1/20 0.48
▸ BLM P54132 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ TDP1 Q9NUW8 1/20 0.48
▸ AHCY P23526 1/20 0.48
▸ ABL1 P00519 5/20 0.43
▸ EGFR P00533 4/20 0.43
▸ SRC P12931 4/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5732373 0.82 ADORA2A (1.00) ADORA2AADORA3ADORA1ADORA2BPI4KB
SCHEMBL31061173 0.81 ADORA2A (1.00) ADORA2AADORA3ADORA1ADORA2BPI4KB
SCHEMBL31061415 0.79 ADORA2A (1.00) ADORA2AADORA3ADORA1ADORA2BPI4KB
SCHEMBL19714857 0.76 ADCY5 (0.65) ADORA2AADORA3ADORA1ADORA2BFBP1
SCHEMBL19714867 0.75 ADCY5 (0.47) ADORA2AADORA3ADORA1ADORA2BFBP1
SCHEMBL23422245 0.72 ADORA2A (0.47) ADORA2AADORA3ADORA1ADORA2BPI4KB
SCHEMBL2980005 0.70 ADORA2A (0.64) ADORA2AADORA3ADORA1ADORA2BPI4KB
SCHEMBL978424 0.70 ADORA2A (1.00) ADORA2AADORA3ADORA1ADORA2BPI4KB
SCHEMBL6302264 0.69 ADORA3 (0.66) ADORA2AADORA3SMN1; SMN2HSPA5HSPA8
SCHEMBL13835070 0.69 ADORA3 (0.66) ADORA2AADORA3SMN1; SMN2HSPA5HSPA8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1043021-B1 PURINE DERIVATIVES FOR THE TREATMENT OF ALLERGIC DISEASES AND SYSTEMIC LUPUS ERYTHEMATOSUS DAINIPPON SUMITOMO PHARMA CO (JP) 2006-05-03 — — EP disclosed
EP-0882727-B9 NOVEL PURINE DERIVATIVES SUMITOMO PHARMA (JP) 2005-06-15 — — EP disclosed
EP-0882727-B1 NOVEL PURINE DERIVATIVES SUMITOMO PHARMA (JP) 2004-12-01 — — EP disclosed
US-6376501-B1 INHIBITING OR REGULATING IMMUNE RESPONSE USING PURINE-DERIVED COMPOUND; NON-STEROIDAL COMPOUND JAPAN ENERGY CORPORATION (JP) 2002-04-23 — — US disclosed
EP-1043021-A1 TYPE 2 HELPER T CELL-SELECTIVE IMMUNE RESPONSE SUPPRESSORS Japan Energy Corporation (JP) 2000-10-11 — — EP disclosed
US-6028076-A FOR INDUCING .ALPHA.-INTERFERON IN A PATIENT HAVING HEPATITIS B OR C, BY ADMINISTERING PURINE DERIVATIVE JAPAN ENERGY CORPORATION (JP) 2000-02-22 — — US disclosed
EP-0882727-A1 NOVEL PURINE DERIVATIVES JAPAN ENERGY CORPORATION (JP) 1998-12-09 — — EP disclosed
Send feedback